VUMERITY® (diroximel fumarate) could lead to fewer relapses. In clinical trials, dimethyl fumarate—which has the same active metabolite as VUMERITY—was shown to work against relapsing multiple sclerosis (MS).
Learn about the potential benefits and risks of VUMERITY, and get tools and tips to help you have a productive conversation with your healthcare provider.
Find out more about clinical trials.
Get details about the potential serious side effects of VUMERITY.
Learn about the most common side effects of VUMERITY and results from a study on stomach tolerability.
Download questions and materials to take to your next appointment.